Advertisement

Tumor Biology

, Volume 32, Issue 3, pp 489–492 | Cite as

Prognostic analysis in node-negative gastric cancer patients in China

  • Miao-zhen Qiu
  • Zhi-qiang Wang
  • Hui-yan Luo
  • Dong-sheng Zhang
  • Zhi-wei Zhou
  • Yu-hong Li
  • Wen-qi Jiang
  • Rui-hua Xu
Research Article

Abstract

Gastric cancer patients with negative nodes were considered to have better outcomes, however, some of them still suffered from disease recurrences or distant metastases after radical resection. A total of 1,020 gastric carcinoma patients receiving treatment in our center between 2003 and 2008 were selected for the analysis. All patients received gastrectomy and D2 lymphadenectomy. Survival analysis was performed with Cox regression model. The final study includes 222 patients. The overall 5-year disease-specific survival rate was 73.0%. Factors bearing significant association with lower survival on univariate analysis included the age of 58 years old or more (P = 0.021), tumor size longer than 4 cm (P < 0.001), presence of angiolymphatic invasion (P = 0.006), proximal site (P = 0.030), serosal invasion (T3+T4, P = 0.003), and higher TNM stage (P < 0.001). Only three factors including serosal invasion, tumor size at least 4.0 cm, and presence of angiolymphatic invasion remained independent negative predictors of survival in multivariable analysis. These parameters can be employed to select node-negative gastric cancer patients for an adjuvant setting and close follow-up scheduling.

Keywords

Node negative Prognostic analysis Gastric cancer China 

Notes

Acknowledgments

This work was supported by National Natural Science Foundation of China grant 30672408, Guangzhou Bureau of Science and Technology grant 2006Z3-E0041 and Sun Yat-Sen University 985 Program Initiation Fund (China). We gratefully thank the staff members in the Department of Medical Oncology and Gastric and Pancreatic Surgery Oncology at Sun Yat-Sen University Cancer Center for their suggestion and assistance.

Conflicts of interest

None

References

  1. 1.
    Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;10:2137–50.CrossRefGoogle Scholar
  2. 2.
    Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, et al. Cancer epidemiology and control in North-Western and Central Asia—past, present and future. Asian Pac J Cancer Prev. 2010;11:17–32.PubMedGoogle Scholar
  3. 3.
    Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449–61.PubMedCrossRefGoogle Scholar
  4. 4.
    Shiu MH, Perrotti M, Brennan MF. Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology. 1989;36:7–12.PubMedGoogle Scholar
  5. 5.
    Bozzetti F, Bonfanti G, Morabito A, Bufalino R, Menotti V, Andreola S, et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet. 1986;162:229–34.PubMedGoogle Scholar
  6. 6.
    Kim JP, Kim YW, Yang HK, Noh DY. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg. 1994;18:872–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Bruno L, Nesi G, Montinaro F, Carassale G, Boddi V, Bechi P, et al. Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol. 2000;74:30–2.PubMedCrossRefGoogle Scholar
  8. 8.
    Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer (AJCC) cancer staging manual. 6th ed. New York: Springer, Inc; 2002. p. 179–88.Google Scholar
  9. 9.
    Byrd DR, SB Edge, Compton CC, et al. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. Chicago: Springer, Inc.; 2010. p. 117–26.Google Scholar
  10. 10.
    Baba H, Maehara Y, Takeuchi H, Inutsuka S, Okuyama T, Adachi Y, et al. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery. 1995;117:165–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Adachi Y, Mori M, Maehara Y, Kitano S, Sugimachi K. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg. 1997;184:373–7.PubMedGoogle Scholar
  12. 12.
    Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, et al. Surgical treatment and outcome for node-negative gastric cancer. Surgery. 1997;121:633–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002;9:562–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35. discussion 835–837.PubMedGoogle Scholar
  15. 15.
    Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, et al. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70–3.PubMedCrossRefGoogle Scholar
  16. 16.
    Setälä LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996;74:766–72.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2010

Authors and Affiliations

  • Miao-zhen Qiu
    • 1
    • 2
  • Zhi-qiang Wang
    • 1
    • 2
  • Hui-yan Luo
    • 1
    • 2
  • Dong-sheng Zhang
    • 1
    • 2
  • Zhi-wei Zhou
    • 1
    • 3
  • Yu-hong Li
    • 1
    • 2
  • Wen-qi Jiang
    • 1
    • 2
  • Rui-hua Xu
    • 1
    • 2
  1. 1.State Key Laboratory of Oncology in South ChinaGuangzhouChina
  2. 2.Department of Medical OncologySun Yat-Sen University Cancer CenterGuangzhouChina
  3. 3.Department of Gastric and Pancreatic SurgerySun Yat-Sen University Cancer CenterGuangzhouChina

Personalised recommendations